Jay Shiao, MD
Radiation Oncology · Kansas City, KSNPI 1063947653
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $1,990 of the $3,316 with a category attached, or 60.0%. 9 manufacturers reported payments, led by Elekta, Inc. at 47.5% of the total. Reporting peaked in 2024 at $1,791 and has fallen 52.6% since, to $850 in 2025.
Across 21 payments — averaging $157.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Elekta, Inc.$2K
- Siemens Medical Solutions USA, Inc.$691
- Boston Scientific$546
- Bioprotect Medical, Inc.$118
- MIM Software Inc.$103
- Palette Life Sciences, Inc.$93
- plus $188 from 3 others
What the payments were for
- Travel & lodging$1,99060%
- Food & beverage$1,25738%
- Education$682%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Elekta, Inc. | 6 | $1,575 |
| Siemens Medical Solutions USA, Inc. | 1 | $691 |
| Boston Scientific | 7 | $546 |
| Bioprotect Medical, Inc. | 1 | $118 |
| MIM Software Inc. | 1 | $103 |
| Palette Life Sciences, Inc. | 2 | $93 |
| Stryker | 1 | $87 |
| AstraZeneca | 1 | $68 |
| Teleflex LLC | 1 | $33 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,316 in reported general payments places this provider in the 75th percentile of 54 radiation oncology providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OrgovyxRelugolix | 60 | $178,245 |
| Tamsulosin Hcl | 132 | $1,930 |
| Oxybutynin Chloride ErOxybutynin Chloride | 27 | $948 |
| Ciprofloxacin Hcl | 49 | $281 |
| Methylprednisolone | 23 | $143 |
| Terazosin Hcl | 16 | $125 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Kansas City
- Ronald ChenKansas City$31K
- Xinglei ShenKansas City$16K
- David AkhavanKansas City$9K
- Fen WangKansas City$7K
- Gregory GanKansas City$5K
- Ronny RotondoKansas City$4K
- Parvesh KumarKansas City$3K
- Ryan MorseKansas City$939
- Christopher LominskaKansas City$466
- Ramesh GadamKansas City$266
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.